See You at the ISCT 2020 Paris Virtual Conference


  We at AventaCell BioMedical Corp Ltd are please to invite you to meet with us at the “ISCT 2020 Paris Virtual Conference: starting on-line live, May 28th to May 29th. You can access the conference remotely; for attending the live plenary, poster and exhibit hall sessions and accessing the recorded concurrent educational sessions on the most current, cell & gene therapy development topics on your own schedule. It is important to know that all concurrent sessions, posters and exhibit hall materials will be available for you to access on this ISCT 2020 Paris Virtual Conference site from May 2020 to May 2021. Paris virtual-4799631?e=e5a773a9da

  Come visit our virtual exhibit booth and meet with us; using the chat box, text messaging, or partnering app, and we’ll update you on the PRT, regulatory and scale-up advances with our UltraGRO™ product line of hPL and FDhPL cell culture supplements. Here are AventaCell’s activities during the ISCT 2020 Paris Virtual Conference. E look forward to seeing you in Paris….virtually!!

COVID-19 Business Continuity Statement


Dear Customer,

  In this time of uncertainty, during this unprecedented COVID-19 outbreak, AventaCell is reaching out to inform all our customers that we are closely monitoring the situation, taking the necessary precautions and procedures to ensure the safety of our products, and keeping our staff safe, with a goal of maintaining global supply of our products. We are following the most conservative guidelines available from leading global and local health authorities (e.g. CDC and WHO) in keeping with achieving this goal.

  Our regional warehouses are well-stocked with product inventory in storage and are taking additional precautionary steps to ensure the safety of our products, as part of our risk management by utilizing validated gamma irradiation in our manufacturing process for our final products; for example UltraGRO™-PURE GI. Gamma irradiation is one of the most widely employed methods for pathogen reduction and commercial gamma irradiation facilities are readily accessible.

  We are also pleased to announce that UltraGRO™-PURE GI has been recognized by multiple regulatory authorities around the world to be compliant with Ancillary Material and Pathogen Reduction Treatment guidance, including;

  •  •USA FDA DMF # 34284
  •  •JAPAN PMDA Certificate
  •  •Eu. Phr. Compliance

  As your partner in cell production, we aim to support you in these challenging times to avoid interruption to your cell research and development plans. If you have any questions, please contact our Customer Service Team or your local Distributor. Thank you for your support of AventaCell BioMedical Corp. Ltd. by choosing to use our products.

  We wish safety and health to you and your families.



2019 ACTO (Sapporo 11.07 - 11.09)

2019 BioJapan (Yokohama 10.09 - 10.11)

2019 KSSCR (Seoul 09.26 - 09.27)

2019 ISCT (Melbourne 05.29 - 06.01)


2019 JSRM (Kobe 03.21 - 03.23)

2019 CPhI (Tokyo 03.18 - 03.20)